(firstQuint)An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects.

 This is a Phase 1, single-center, prospective, randomized, double-blind study of multiple ascending doses (MAD) of CD101 Injection administered IV to healthy adult subjects.

 In this study, subjects in 3 cohorts of 8 subjects each will be randomized to receive multiple IV doses of CD101 Injection or placebo infusions.

 Dose levels of CD101 Injection to be assessed will follow an ascending multiple-dose regimen.

.

 An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects@highlight

A multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of CD101 Injection in Healthy Subjects.

